oncology

Professor Anna Nowak awarded the inaugural Professor M. Tattersall Heroes Award

The remarkable success of first line combined immunochemotherapy in patients with mesothelioma was far from guaranteed until research in Australia managed to demonstrate its potential to improve survival outcomes beyond standard care. The anticipated findings from the single arm phase 2 DREAM trial were widely reported in September last year. It showed the combination of ...

Already a member?

Login to keep reading.


OR
© 2022 the limbic